文章基本信息

标题：Frequência da síndrome metabólica em pacientes esquizofrênicos
本地全文：下载
作者：Juscelino de Souza Borges Neto ; Juliana Mara Flores Bicalho ; Thais Marques da Silva 等
期刊名称：Research, Society and Development
电子版ISSN：2525-3409
出版年度：2021
卷号：10
期号：11
页码：1-10
DOI：10.33448/rsd-v10i11.18904
语种：English
出版社：Grupo de Pesquisa Metodologias em Ensino e Aprendizagem em Ciências
摘要：Introduction: Metabolic Syndrome (MS) is characterized by a set of factors that increase the risk of cardiovascular diseases related to central obesity and insulin resistance. The numbers of morbidity and mortality and socioeconomic costs to public health services are alarming and their prevalence varies according to the diagnostic criteria and the population studied. The world population has a prevalence of 25%, considering schizophrenic patients, the mean MS prevalence rate found is 32.5%. Schizophrenia is a chronic psychosis without a defined cause, a multifactorial disease that appears slowly or suddenly and is related to health problems, such as difficulty with self-care, thought processing, interpersonal relationships, which favors social isolation and difficulty in the rehabilitation process. Objectives: To determine the prevalence of metabolic syndrome (MS) in schizophrenic patients according to the international diagnostic criteria of NCEP / ATP / III and IDF. Methods: Cross-sectional and analytical epidemiological study. Socioeconomic, anthropometric, clinical and biochemical data were collected. For data analysis, absolute, relative and multivariate frequency measures were used, and a significance level of 5% was considered. Results: The frequency of MS was 38.9 and 43.1%, NCEP / ATP / III and IDF respectively. Women had a greater presence of MS and altered waist circumference than men. The group with MS changed more frequently in terms of individual components changed compared to the group without MS. Conclusion: The frequency of MS and its individual components altered was high, especially among women.
关键词：Metabolyc Syndrome;Heart Disease Risk Factors;Schizophrenia.